Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose

Breast Cancer Research and Treatment

Volumn 68, Issue 3, 2001, Pages 199-210

  Lind, Pehr A R M ^a,b,c   Wennberg, Berit ^a   Gagliardi, Giovanna ^a   Fornander, Tommy ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

3 dimensional dose planning; Breast cancer; Pulmonary side effects; Radiotherapy

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HEALTH CARE QUALITY; HISTOLOGY; HUMAN; LUNG; LUNG DISEASE; MASTECTOMY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; STANDARD; SWEDEN;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG; LUNG DISEASES; MASTECTOMY; MIDDLE AGED; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; SWEDEN;

EID: 0035431859     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012292019599     Document Type: Article

References (41)

1. Lind PARM, Gagliardi G, Wennberg B, Fornander T: A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol 36: 509-515, 1997
2. Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR: Radiation pneumonitis in breast cancer treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 21: 355-360, 1991
3. Bartelink H, Garavaglia G, Johansson K-A, Mijnheer BJ, VandenBogaert W, vanTienhoven G: Quality assurance in conservative treatment of early breast cancer. Radiother Oncol 22: 323-326, 1991
4. Bornstein BA, Cheng CW, Rhodes LM, Rashid H, Stomper PC, Siddon RL: Can simulation measurements be used to predict the irradiated lung volume in the tangential fields in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 18: 181-187, 1990
5. Lind PARM: Short-term pulmonary side-effects following radiation therapy in breast cancer. Doctoral thesis, Karolinska Institute, Stockholm, Sweden, 1999
6. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [see comments]. Ini J Radiat Oncol Biol Phys 45(2): 323-329, 1999
7. Graham MV, Purdy JA, Emami B, Matthews JW, Harms WB: Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 33: 993-1000, 1995
8. Lind PARM, Rosfors S, Wennberg B, Glas U, Bevegård S, Fornander T: Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional tretament planning. Radiother Oncol 49: 245-254, 1998
9. Marks LB, Halperin EC, Prosnitz LR, Ross M, Vredenburgh JJ, Rosner GL: Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer with >10 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 23: 1021-1026, 1992
10. Gage I, Bond S, Davidson NE, Clarke BV, McIntyre J, Fetting J: Minimal acute toxicity associated with locoregional radiation therapy following 2 high-dose chemotherapy regimens (HDC) supported with autologous marrow/stem-cell transplantation in high risk breast cancer patients. Proc Am Soc Clin Oncol 17: 121a(abstr. 463), 1998
11. Taghian AG, Assaad S, Kuter I, Younger J, Schoenthaler R, Czito B: Increased risk of radiation pneumonitis in breast cancer patients treated by concomitant taxol and radiation therapy. Int J Radiat Oncol Biol Phys 45(3, suppl): 316a (abstr. 2074), 1999
12. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J: Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 88: 918-922, 1996
13. Bjermer L, Franzén L, Littbrand B, Nilsson K, Ångström T, Henriksson R: Effects of smoking and irradiated volume of inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. Cancer Res 50: 2027-2030, 1990
14. Theuws JC, Kwa SL, Wagenaar AC, Boersma LJ, Damen EM, Muller SH: Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 48(1): 33-43, 1998
15. Cancer Therapy Evaluation Program, Common Toxicity Criteria, Version 2.0 DCTD, NCI, DHHS, March 1998
16. Siegel S, Catellan Jr N: Nonparametric Statistics for Behavioral Sciences. 2nd ed. McGraw-Hill, New York, 1988
17. Bentel GC, Marks LB, Hardenbergh PH, Prosnitz LR: Routine CT-based treatment planning for patients with breast cancer. Int J Radiat Oncol Biol Phys 42: 127a (abstr. 5), 1998
18. Gagliardi G: Modeling heart and lung complication data in radiation therapy of the breast. PhD thesis, Stockholm University, Stockholm, Sweden, 1998
19. Gyenes G: Cardiac side-effects of adjuvant radiotherapy for early breast cancer. Doctoral thesis, Karolinska Institute, Stockholm, Sweden, 1997
20. Theuws JC, Seppenwoolde Y, Kwa SL, Boersma LJ, Damen EM, Baas P: Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys 47(5): 1201-1208, 2000
21. Theuws JC, Muller SH, Seppenwoolde Y, Kwa SL, Boersma LJ, Hart GA: Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: a follow-up study. J Clin Oncol 17(10): 3091-3100, 1999
22. Kaufman J, Gunn W, Hartz AJ, Fischer M, Hoffman RG, Schlueter DP: The pathophysiologic and roetgenologic effects of chest irradiation in breast carcinoma. Int J Radiat Oncol Biol Phys 12: 887-893, 1986
23. Lind PARM, Bylund H, Wennberg B, Svensson C, Svane G: Abnormalities on chest radiographs following radiation therapy for breast cancer. European Radiol 10: 484-489, 2000
24. Lind PA, Svane G, Gagliardi G, Svensson C: Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer (see comments]. Int J Radiat Oncol Biol Phys 43(3): 489-496, 1999
25. Byhardt RW, Martin L, Pajak TF, Shin KH, Emami B, Cox JD: The influence of held size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Radiat Oncol Biol Phys 27(3): 537-544, 1993
26. Kwa SL, Lebesque JV, Theuws JC, Marks LB. Munley MT, Bentel G: Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42(1): 1-9, 1998
27. Liao ZX, Travis EL, Tucker SL: Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung (see comments]. Int J Radiat Oncol Biol Phys 32(5): 1359-1370, 1995
28. Lyman JT, Wolbarst AB: Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13: 103-109, 1987
29. Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R: Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21(1): 137-146, 1991
30. Jackson A, Kutcher GJ, Yorke ED: Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 20: 613-625, 1993
31. Yorke ED, Kutcher GJ, Jackson A, Ling CC: Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 26(3): 226-237, 1993
32. Niemierko A, Goitein M: Modeling of normal tissue response to radiation: the critical volume model [see comments]. Int J Radiat Oncol Biol Phys 25(1): 135-145, 1993
33. Kwa S, Theuws J, Wagenaar A, Damen E, Boersma L, Baas P: Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48: 61-69, 1998
34. Marks LB, Hebert ME, Bentel G, Spencer DP, Sherouse GW, Prosnitz LR: To treat or not to treat the internal mammary nodes: a possible compromise. Int J Radiat Oncol Biol Phys 29(4): 903-909, 1994
35. Freedman GM, Fowble BL, Nicolaou N, Sigurdson ER, Torosian MH, Boraas MC: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? [see comments]. Int J Radiat Oncol Biol Phys 46(4): 805-814, 2000
36. Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E: Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 47(4): 883-894, 2000
37. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337: 949-955, 1997
38. Overgaard M, Jensen M-B, Overgaard J, Hansen PS, Rose C, Andersson M: Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Group DBCG 82c randomised trial. Lancet 353(9165): 1641-1648, 1999
39. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337(14): 956-962, 1997
40. Diab SG, Hilsenbeck SG, deMoor C, Clark GM, Osborne CK, Ravdin PM: Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. J Clin Oncol 16: 1655-1660, 1998
41. Bartelink H, Borger J, Fourquet A, Gerard JP, Horiot JC, Kurtz J: Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer. EORTC-protocol 22922-10925, 1996